Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Common issues such as hair loss, nausea, skin problems and fatigue can seriously affect patients’ quality of life.

Rid Your Yard and Garden of Moles Overnight Using These Methods Hurricane Helene leaves "unimaginable" destruction across 5 ...

Roche is planning to launch 13 medicines by the end of the decade and cut research costs for new drugs by a fifth, according to a strategy update on Monday.

The poll is composed of four Class AA coaches and four Class A coaches that represent all the regions of the State. *First place votes are in parentheses.  Oak Glen (18-2-3)    57 points (5)  Philip B ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Weight loss drugs such as Ozempic, Wegovy and Saxenda can help some people lose more weight than others, and a new study has revealed some key factors that might impact success. "In patients with ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...